Jesus Castilla

Summary

Country: Spain

Publications

  1. pmc Use of medical care during pandemic (H1N1) 2009, Navarre, Spain
    Rosana Burgui
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Emerg Infect Dis 17:1463-6. 2011
  2. pmc Social factors related to the clinical severity of influenza cases in Spain during the A (H1N1) 2009 virus pandemic
    José María Mayoral
    Servicio de Vigilancia epidemiológica de Andalucia, Sevilla, Spain
    BMC Public Health 13:118. 2013
  3. doi request reprint Trends in influenza vaccine coverage among primary healthcare workers in Spain, 2008-2011
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Prev Med 57:206-11. 2013
  4. doi request reprint Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Clin Infect Dis 57:167-75. 2013
  5. ncbi request reprint Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis
    J Castilla
    Instituto de Salud Publica de Navarra Public Health Institute of Navarre, Pamplona, Spain
    Euro Surveill 18:2. 2013
  6. doi request reprint Risk factors and effectiveness of preventive measures against influenza in the community
    Jesus Castilla
    Instituto de Salud Publica de Navarra, 31003 Pamplona, Spain
    Influenza Other Respir Viruses 7:177-83. 2013
  7. doi request reprint Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 30:195-200. 2012
  8. doi request reprint Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 30:539-43. 2012
  9. pmc Mortality by causes in HIV-infected adults: comparison with the general population
    Pablo Aldaz
    Centro de Salud de San Juan, Servicio Navarro de Salud, Avda Barañain 26, 31008 Pamplona, Spain
    BMC Public Health 11:300. 2011
  10. doi request reprint Effectiveness of Jeryl Lynn-containing vaccine in Spanish children
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 27:2089-93. 2009

Detail Information

Publications66

  1. pmc Use of medical care during pandemic (H1N1) 2009, Navarre, Spain
    Rosana Burgui
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Emerg Infect Dis 17:1463-6. 2011
    ..This value was lower for adults (53%, 39/74) than for children <15 years of age (74%, 68/92), as well as for those with cases secondary to another household case (58%, 64/111)...
  2. pmc Social factors related to the clinical severity of influenza cases in Spain during the A (H1N1) 2009 virus pandemic
    José María Mayoral
    Servicio de Vigilancia epidemiológica de Andalucia, Sevilla, Spain
    BMC Public Health 13:118. 2013
    ..The objective of this study was to assess the role of individual and social determinants in hospitalizations due to influenza A (H1N1) 2009 infection...
  3. doi request reprint Trends in influenza vaccine coverage among primary healthcare workers in Spain, 2008-2011
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Prev Med 57:206-11. 2013
    ..To evaluate trends in seasonal influenza vaccination coverage in primary healthcare workers (PHCWs) in Spain between 2008 and 2011...
  4. doi request reprint Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Clin Infect Dis 57:167-75. 2013
    ..We designed a case-control study to compare the effectiveness of the influenza vaccine in preventing outpatient, inpatient, and severe or fatal cases of laboratory-confirmed influenza...
  5. ncbi request reprint Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis
    J Castilla
    Instituto de Salud Publica de Navarra Public Health Institute of Navarre, Pamplona, Spain
    Euro Surveill 18:2. 2013
    ..In a nested test-negative case-control analysis the adjusted VE in preventing laboratory-confirmed influenza was 86% (95% CI: 45 to 96). These results suggest a high protective effect of the vaccine...
  6. doi request reprint Risk factors and effectiveness of preventive measures against influenza in the community
    Jesus Castilla
    Instituto de Salud Publica de Navarra, 31003 Pamplona, Spain
    Influenza Other Respir Viruses 7:177-83. 2013
    ..The role of different risk exposures and preventive measures against influenza has not been well established...
  7. doi request reprint Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 30:195-200. 2012
    ..The close estimates obtained in the cohort and the test-negative case-control analyses suggest good control of biases...
  8. doi request reprint Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 30:539-43. 2012
    ..No differences between the two vaccines were detected (p=0.4523). Both vaccines were highly effective in preventing cases and hospital admissions in children due to rotavirus gastroenteritis...
  9. pmc Mortality by causes in HIV-infected adults: comparison with the general population
    Pablo Aldaz
    Centro de Salud de San Juan, Servicio Navarro de Salud, Avda Barañain 26, 31008 Pamplona, Spain
    BMC Public Health 11:300. 2011
    ..We compared mortality by cause of death in HIV-infected adults in the era of combined antiretroviral therapy with mortality in the general population in the same age and sex groups...
  10. doi request reprint Effectiveness of Jeryl Lynn-containing vaccine in Spanish children
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 27:2089-93. 2009
    ..2-8.4) and those who had received the second dose 3 or more years before study enrolment (OR=10.2; 1.5-70.7). Early waning of immunity in children after the second dose may contribute to reduced vaccine effectiveness for mumps prevention...
  11. ncbi request reprint Mumps outbreak in Navarre region, Spain, 2006-2007
    J Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Euro Surveill 12:E070215.1. 2007
  12. pmc A large Legionnaires' disease outbreak in Pamplona, Spain: early detection, rapid control and no case fatality
    J Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Epidemiol Infect 136:823-32. 2008
    ..Eight days after closing the towers, new cases ceased appearing. Early detection and rapid coordinated medical and environmental actions permitted immediate control of the outbreak and probably contributed to the null case fatality...
  13. ncbi request reprint [Epidemiology of tuberculosis in Navarre]
    J Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    An Sist Sanit Navar 30:21-32. 2007
    ..Methods. An analysis was made of the cases of tuberculosis reported in the 1993-2006 period, completed with microbiological information and data from other registries...
  14. doi request reprint Population-based contact investigation of a cluster of tuberculosis cases in a small village
    J Castilla
    Insituto de Salud Pública de Navarra, Pamplona, Spain
    Epidemiol Infect 137:1426-35. 2009
    ..This study suggests that a considerable percentage of the episodes of TB transmission in young people may escape detection in conventional contact studies...
  15. doi request reprint [Resurgence of mumps in the vaccine era. Factors involved in an outbreak in Navarre, Spain, 2006-2007]
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Espana
    Med Clin (Barc) 133:777-82. 2009
    ..We analysed a mumps outbreak that occurred in Navarre between August 2006 and December 2007, in which vaccinated persons were widely affected...
  16. ncbi request reprint [The 2009 H1N1 flu pandemic in Navarre, Spain]
    Jesus Castilla
    Instituto de Salud Pública, Pamplona, Spain
    An Sist Sanit Navar 33:287-95. 2010
    ..To describe flu activity during the 2009-2010 pandemic in Navarre and compare it to previous seasons...
  17. doi request reprint [Differences between summer and fall waves of influenza in the pandemic of influenza (H1N1) 2009 in Navarre, Spain]
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Leyre 15, Pamplona
    Rev Esp Salud Publica 85:47-56. 2011
    ..Two waves of influenza (H1N1) 2009 were produced in Navarre in 2009, one in the summer and the other in the fall. We aim to compare the characteristics of the two epidemic waves...
  18. doi request reprint [Impact of vaccination against influenza (H1N1) 2009 in Navarre: comparison of different scenarios]
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Leyre 15, Pamplona
    Rev Esp Salud Publica 85:105-11. 2011
    ..A specific vaccination campaign against influenza A (H1N1) was conducted in 2009. We evaluated its impact in Navarre...
  19. ncbi request reprint [Incidence of influenza and influenza vaccine effectiveness in the 2004-2005 season]
    J Castilla
    Instituto de Salud Pública, Pamplona
    An Sist Sanit Navar 29:97-106. 2006
    ..To quantify the incidence of flu in different groups of the population of Navarra in the 2004-2005 season, and to evaluate the effectiveness of anti-flu vaccination...
  20. doi request reprint Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 29:5919-24. 2011
    ..Pandemic vaccine was effective in preventing MA-ILI and confirmed cases of influenza A(H1N1)2009 in the 2009-2010 season...
  21. pmc Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study
    Iván Martínez-Baz
    Instituto de Salud Publica de Navarra, Leyre 15, 31003, Pamplona, Spain
    BMC Public Health 13:191. 2013
    ..This study evaluates the effectiveness of the trivalent influenza vaccine in preventing outpatient illness and hospitalizations from laboratory-confirmed influenza in the 2010-2011 season...
  22. ncbi request reprint [Invasive pneumococcal disease in children younger than 5 years in Navarra, Spain (2000-2005). Impact of the conjugate vaccine]
    Aurelio Barricarte
    Instituto de Salud Publica de Navarra, Pamplona, Navarra, Espana
    Med Clin (Barc) 129:41-5. 2007
    ..The 7-valent pneumococcal conjugate vaccine (PCV7) has been commercialized in Spain since June 2001. We aim to evaluate the impact of this vaccine in the incidence of invasive pneumococcal disease (IPD) in Navarre...
  23. pmc B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    J Clin Microbiol 47:463-5. 2009
    ..3 x 10(5) in Navarra, Spain, in 2007. Eleven percent of cases were fatalities, and 74% of cases were individuals 10 to 24 years old. This is the third cluster associated with this strain in northern Spain since 2001...
  24. ncbi request reprint Evaluating the risk of HIV transmission through unprotected orogenital sex
    Jorge del Romero
    Centro Sanitario Sandoval, Servicio Regional de Salud, Madrid, Spain
    AIDS 16:1296-7. 2002
    ..After an estimated total of over 19,000 unprotected orogenital exposures with the infected partner not a single HIV seroconversion occurred...
  25. ncbi request reprint Impact of chronic hepatitis C on HIV-1 disease progression
    Juan Carlos Martín
    Service of Infectious Diseases, Hospital Carlos III, Carlos III Institute of Health, Madrid, Spain
    HIV Clin Trials 5:125-31. 2004
    ..We have analyzed the impact of HCV on CD4 counts and plasma HIV RNA in a large group of HIV-positive individuals...
  26. ncbi request reprint [Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results]
    Ana María Caro-Murillo
    Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Spain
    Enferm Infecc Microbiol Clin 25:23-31. 2007
    ..To describe the methodology and baseline results of the Spanish cohort of naïve HIV-infected patients included in the Research Network on HIV/AIDS (CoRIS)...
  27. doi request reprint Factors associated with continued adherence to influenza vaccination in the elderly
    Iván Martínez-Baz
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Prev Med 55:246-50. 2012
    ..We aimed to analyze the factors influencing continued adherence to influenza vaccination in elderly persons vaccinated in the preceding season...
  28. ncbi request reprint [Trends in mortality and causes of death among persons with HIV infection, 1985-2004]
    Pablo Aldaz
    Instituto de Salud Publica de Navarra, Departamento de Medicina Preventiva y Salud Publica, Universidad de Navarra, Spain
    Enferm Infecc Microbiol Clin 25:5-10. 2007
    ..To describe the changes in causes of death among persons with HIV infection...
  29. ncbi request reprint [Evaluation of the surveillance system for human immunodeficiency virus infections of Navarra, Spain, 1985-2003]
    Ana María Caro-Murillo
    Programa de Epidemiologia Aplicada de Campo, Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Madrid, Espana
    Rev Esp Salud Publica 81:387-98. 2007
    ..Navarra has an information system of HIV diagnoses working since the beginning of the epidemic up to the present day. This study aims at describing and evaluating this system, focusing on its sensitivity...
  30. ncbi request reprint Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study
    Aurelio Barricarte
    Instituto de Salud Publica de Navarra, Spain
    Clin Infect Dis 44:1436-41. 2007
    ..The 7-valent pneumococcal conjugate vaccine (PCV7) has shown high efficacy in preventing invasive pneumococcal disease (IPD) caused by vaccine serotypes. We aimed to assess the overall effectiveness of PCV7 against IPD in Navarra, Spain...
  31. doi request reprint [Effect of the time between symptom onset, swabbing and testing on the detection of influenza virus]
    Iván Martínez-Baz
    Instituto de Salud Publica de Navarra, Pamplona, Espana
    Enferm Infecc Microbiol Clin 30:11-4. 2012
    ..We evaluated the influence on the laboratory results of the time since the onset of symptoms to swabbing (TSS) and from then until laboratory processing (TSL)...
  32. doi request reprint Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain
    M Guevara
    Instituto de Salud Publica de Navarra, Navarre, Spain
    Clin Microbiol Infect 15:1013-9. 2009
    ..The pattern of serotypes causing IPD has changed, in both children and adults, following the increased coverage of PCV7, although the incidence has been reduced only slightly...
  33. ncbi request reprint [Influence of distinct criteria for selecting patients for swabbing on estimation of the effectiveness of the influenza vaccine]
    Iván Martínez-Baz
    Instituto de Salud Publica de Navarra, Pamplona, España Ciber de Epidemiología y Salud Pública CIBERESP, España Electronic address
    Gac Sanit 28:225-9. 2014
    ..To estimate the effectiveness of the influenza vaccine under different criteria for selecting patients for swabbing...
  34. ncbi request reprint Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013
    Marcela Guevara
    Instituto de Salud Publica de Navarra, Pamplona, Spain CIBER Epidemiología y Salud Pública CIBERESP, Spain Electronic address
    Vaccine 32:2553-62. 2014
    ..The incidence of IPD has declined and the pattern of serotypes causing IPD has changed notably in children and moderately in adults following the replacement of PCV7 by PCV13...
  35. doi request reprint [Seroprevalence study of hepatitis B among orienteers]
    Victoria Hernando
    Programa de Epidemiologia Aplicada de Campo, Instituto de Salud Carlos III, Madrid, Espana
    Med Clin (Barc) 132:649-53. 2009
    ..Our objectives were to detect asymptomatic cases involved in an outbreak of hepatitis B, to assess the seroprevalence of hepatitis B (HB) in orienteers and to establish recommendations...
  36. ncbi request reprint [Heptavalent-pneumococcal conjugate vaccine (Prevenar). Differences in effectiveness between populations]
    M Guevara
    Instituto de Salud Pública, Pamplona 31003, Spain
    An Sist Sanit Navar 31:171-92. 2008
    ..In these cases, VNC7v could be reserved for children with IPD risk factors...
  37. ncbi request reprint [Evolution of the epidemiological characteristics of tuberculosis in Navarra (1994-2003)]
    J Castilla
    Instituto de Salud Pública, Pamplona, 31003, Spain
    An Sist Sanit Navar 28:237-45. 2005
    ..To describe the changes in the incidence and the epidemiological profile of tuberculosis in Navarra...
  38. doi request reprint [Increased primary care consultations for upper respiratory tract infections and for fever coinciding with a wave of influenza]
    Pablo Aldaz
    Centro de Salud de San Juan, Servicio Navarro de Salud, Plaza Obispo Irurita s n, Pamplona, Espana
    Rev Esp Salud Publica 85:113-20. 2011
    ..A wave of influenza A (H1N1) 2009 was registered in the summer of 2009. We evaluated its repercussion on primary care consultations not diagnosed as influenza...
  39. ncbi request reprint Characteristics and trends of newly diagnosed HIV-infections, 2000-2004
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Espana
    Gac Sanit 20:442-8. 2006
    ..To describe the characteristics and trends of newly diagnosed HIV-infections...
  40. ncbi request reprint Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence
    Jesus Castilla
    Secretaria del Plan Nacional sobre Sida, Ministerio de Sanidad y Consumo, Madrid, Spain
    AIDS 16:1945-51. 2002
    ..To assess the repercussion of late diagnosis of HIV infection on AIDS incidence in the era of highly active antiretroviral therapy...
  41. ncbi request reprint [Communicable disease surveillance in Navarre, 2004]
    J Castilla
    Sección de Enfermedades Infecciosas y Control de Brotes, Instituto de Salud Pública, Pamplona
    An Sist Sanit Navar 28:93-104. 2005
    ..42), without any epidemiological relation between them. The incidence of imported diseases rose, with 12 cases of malaria, 8 of shigellosis, 5 of hepatitis A and 2 of legionnaire's disease acquired outside Spain...
  42. ncbi request reprint Current legionellosis outbreak with 139 cases in Pamplona, Spain
    A Barricarte
    Instituto de Salud Pública, Navarra, Spain
    Euro Surveill 11:E060608.1. 2006
  43. ncbi request reprint [Elevated risk of HIV infection in homosexual men even after contact with the health system]
    Alicia Barrasa
    Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Espana
    Enferm Clin 17:302-8. 2007
    ..To determine the incidence of HIV seroconversion and to evaluate the characteristics associated with a greater risk of seroconversion in homosexual men in the period 2000-2003...
  44. ncbi request reprint [Compulsory Diseases Notification (CDN) in Navarre 2003]
    M Urtiaga
    Sección de Enfermedades Infecciosas y Control de Brotes, Instituto de Salud Pública, Pamplona
    An Sist Sanit Navar 27:87-97. 2004
    ..8 cases per 100,000 inhabitants (EI: 0.92), without any epidemiological relation between them. There were 7 cases of malaria, all imported. The incidence of food borne infections has fallen (EI: 0.71)...
  45. ncbi request reprint Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    J Acquir Immune Defic Syndr 40:96-101. 2005
    ..When HAART became widely available, a reduction of approximately 80% in heterosexual transmission of HIV was observed, irrespective of changes in other factors that affect transmission...
  46. doi request reprint [Delayed diagnosis of HIV infection in Spain]
    Jesus Oliva
    Unidad de Epidemiología del VIH SIDA, Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Espana
    Enferm Infecc Microbiol Clin 28:583-9. 2010
    ....
  47. ncbi request reprint [Social and work conditions, risk behavior and prevalence of sexually transmitted diseases among female immigrant prostitutes in Madrid (Spain)]
    María José Belza
    Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Spain
    Gac Sanit 18:177-83. 2004
    ....
  48. ncbi request reprint [Present situation and future perspectives of the epidemic of HIV and AIDS in Spain]
    J Castilla
    Instituto de Salud Publica de Navarra, Pamplona
    An Sist Sanit Navar 29:13-25. 2006
    ..8 per 100,000 inhabitants) and over 1,600 deaths from AIDS (3.8 per 100,000). One third of the people who developed AIDS in 2004 had not until then been diagnosed with HIV, which prevented starting the antiretroviral treatment in time...
  49. ncbi request reprint [Epidemiology of notifiable diseases in Navarre, 2006]
    J Castilla
    Instituto de Salud Publica de Navarra, Pamplona
    An Sist Sanit Navar 30:233-44. 2007
    ..Eleven cases of malaria were registered, all imported. Notifications of toxic food infections has continued to fall (IE:0.48)...
  50. ncbi request reprint [Dealing with tuberculosis in primary care. Contact tracing procedures]
    F Teruel
    Centro de vacunación internacional, Delegación del Gobierno en Navarra, Pamplona, Spain
    An Sist Sanit Navar 30:87-98. 2007
    ..In the treatment of both active tuberculosis and latent infection it is essential to obtain good patient adherence...
  51. ncbi request reprint [M. tuberculosis complex drug resistance in Navarre: differences between the local and immigrant populations]
    A Navascués Ortega
    Servicio de Microbiologia, Hospital de Navarra, Pamplona, 31008, Spain
    An Sist Sanit Navar 32:243-8. 2009
    ..The aim of this article is to evaluate the frequency of resistance to the four principal antitubercular drugs in both the local and immigrant populations...
  52. ncbi request reprint [Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006]
    M García Cenoz
    Instituto de Salud Publica de Navarra, 31003 Pamplona, Spain
    An Sist Sanit Navar 31:71-80. 2008
    ..7 per 1,000 cases). This epidemiological pattern is similar to that found in other places before the introduction of the vaccine...
  53. ncbi request reprint Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme
    Elizaga N Ascunce
    Breast Cancer Screening Programme, Instituto de Salud Pública, Leyre 15, 31003 Pamplona, Spain
    J Med Screen 14:14-20. 2007
    ..The aim of this study was to assess changes in the trend of breast cancer mortality in Navarre, and the effect that a screening programme may have had on these changes...
  54. ncbi request reprint [HIV prevalence among homosexual and bisexual men in Spain, 1992-2000]
    J Del Romero
    Centro Sanitario Sandoval Madrid Spain
    Med Clin (Barc) 119:413-5. 2002
    ..Our purpose was to describe the time trend in HIV seroprevalence among homo/ bisexual men...
  55. ncbi request reprint Sentinel surveillance of HIV infection in HIV test clinics, Spain 1992-2002
    A Barrasa
    Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Spain
    Euro Surveill 9:27-9. 2004
    ..In 2002, the highest HIV prevalence was found in injecting drug users (IDUs) (14.2%), homo/bisexual men (7.5%) and individuals who had an HIV infected heterosexual partner (10.2%)...
  56. ncbi request reprint [Dialysis and transplantation report of the Spanish Nephrology Society and Autonomous Registries for the year 2000]
    J J Amenabar
    Nefrologia 22:310-7. 2002
  57. ncbi request reprint [Dialysis and Transplant Registry of the Spanish Society of Nephrology and regional registries. Rapport 2001]
    K López Revuelta
    Comité de Regristro de la SEN, comunidades y Registros Autonómicos
    Nefrologia 24:21-6, 28-33. 2004
  58. ncbi request reprint [Prevalence of the HIV infection in patients seen at specialized diagnosis centers in 9 cities in Spain from 1992 to 2001]
    A Barrasa
    Centro Nacional de Epidemiologia, Madrid, Espana
    Aten Primaria 33:483-8. 2004
    ..To describe the prevalence of HIV infection in persons tested between 1992 and 2001...
  59. pmc Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples
    B Marincovich
    Centro Sanitario Sandoval, Servicio Madrileño de Salud Madrid, Spain
    Sex Transm Infect 79:160-2. 2003
    ..To analyse hepatitis C virus (HCV) transmission in a cohort of heterosexual couples who are discordant both for HIV and for HCV...
  60. ncbi request reprint Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays
    C de Mendoza
    Service of Infectious Diseases, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain
    J Med Virol 64:217-22. 2001
    ....
  61. ncbi request reprint [Women who are partners of a man infected by HIV: description of their characteristics and appraisal of risk]
    J Del Romero
    Centro Sanitario Sandoval, Instituto Madrileño de Salud, Madrid, Spain
    Aten Primaria 34:420-6. 2004
    ..To describe the situations of risk and the prevalence of HIV in women with a heterosexual partner infected by HIV...
  62. ncbi request reprint Time trend in incidence of HIV seroconversion among homosexual men repeatedly tested in Madrid, 1988--2000
    J Del Romero
    Centro Sanitario Sandoval, Servicio Regional de Salud, Madrid, Spain
    AIDS 15:1319-21. 2001
    ..After declining from 1988 (4.71 per 100 PY), the incidence rate began a significant upward trend, reaching a figure of 2.16 per 100 PY in 2000. These findings ought to alert surveillance systems and prevention programmes...
  63. ncbi request reprint [Estimating the completeness of AIDS reporting in Spain]
    A Barrasa
    , , Instituto de Salud Carlos III, Madrid, Spain
    Gac Sanit 15:482-9. 2001
    ..The notification of deaths to the AIDS reporting system presents great deficiencies...
  64. ncbi request reprint [HIV seroprevalence and exposure categories among adolescents tested at a sexually transmitted clinic diseases. Madrid, 1986-2000]
    R Gómez-Lázaro
    Centro Nacional de Epidemiología Instituto de Salud Carlos III Madrid
    Gac Sanit 15:202-8. 2001
    ..To describe the time-trend in exposure categories and HIV seroprevalence among adolescents who underwent to voluntary testing in the period 1986-2000...
  65. ncbi request reprint [Progress in the control of HIV infection and AIDS in Navarre, 1985-2003]
    C Moreno-Iribas
    Instituto de Salud Publica de Navarra
    An Sist Sanit Navar 27:221-31. 2004
    ..It is necessary to insist on prevention and to adapt this to the new situation...
  66. pmc Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999
    J del Amo
    Plan Nacional del SIDA, Ministerio de Sanidad y Consumo, Spain
    Sex Transm Infect 78:255-60. 2002
    ..To study HIV progression from seroconversion over a 15 year period and measure the population effectiveness of highly active antiretroviral therapy (HAART)...